论文部分内容阅读
血管紧张素转换酶抑制剂(ＡＣＥＩ)已广泛用于心血管病的治疗。高钾血症是使用该类药物的一种并发症。本研究探讨了应用ＡＣＥＩ患者高钾血症的发生率及其相关危险因素。病人和方法 于1992年～1993年两年间接受ＡＣＥＩ治疗的1818例门诊患者中,选择初次血钾浓度≥51ｍｍｏｌ/
Angiotensin-converting enzyme inhibitors (ACEIs) have been widely used in the treatment of cardiovascular disease. Hyperkalemia is a complication of the use of such drugs. This study explored the incidence of hyperkalemia and its associated risk factors in patients with ACEI. Patients and methods In 1818 outpatients who underwent ACEI for two years between 1992 and 1993, the initial serum potassium concentration was selected to be ≥51 mmol /